StockData
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/303% above fair value
$27.40−2.96 (-9.75%)

Close on Nov 17, 2026Market cap $2.64BP/E –Yield –

IDEAYA Biosciences cash

Cash and short-term investments held at the end of each period.

IDEAYA Biosciences's cash was $828.96M at Jun 30, 2026. For fiscal 2025 it was $639.39M, down 5.6% from the year before. The highest annual figure on record is $677.12M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$639.39M-5.6%
FY2024Dec 31, 2024$677.12M+28.9%
FY2023Dec 31, 2023$525.11M+43.9%
FY2022Dec 31, 2022$364.94M+47.8%
FY2021Dec 31, 2021$246.88M-13.0%
FY2020Dec 31, 2020$283.69M+186.4%
FY2019Dec 31, 2019$99.06M+10.0%
FY2018Dec 31, 2018$90.07M+1393.2%
FY2017Dec 31, 2017$6.03M-37.8%
FY2016Dec 31, 2016$9.69M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$828.96M+23.8%
Q1 FY2026Mar 31, 2026$671.20M-3.1%
Q4 FY2025Dec 31, 2025$639.39M-5.6%
Q3 FY2025Sep 30, 2025$786.89M-14.5%
Q2 FY2025Jun 30, 2025$669.74M-4.5%
Q1 FY2025Mar 31, 2025$692.51M-0.9%
Q4 FY2024Dec 31, 2024$677.12M+28.9%
Q3 FY2024Sep 30, 2024$920.03M+96.3%
Q2 FY2024Jun 30, 2024$701.66M+42.1%
Q1 FY2024Mar 31, 2024$698.77M+105.8%
Q4 FY2023Dec 31, 2023$525.11M+43.9%
Q3 FY2023Sep 30, 2023$468.75M+21.4%
Q2 FY2023Jun 30, 2023$493.72M+83.8%
Q1 FY2023Mar 31, 2023$339.47M+34.4%
Q4 FY2022Dec 31, 2022$364.94M+47.8%
Q3 FY2022Sep 30, 2022$386.24M+46.0%
Q2 FY2022Jun 30, 2022$268.62M-2.0%
Q1 FY2022Mar 31, 2022$252.60M-16.4%
Q4 FY2021Dec 31, 2021$246.88M-13.0%
Q3 FY2021Sep 30, 2021$264.55M-5.1%
Q2 FY2021Jun 30, 2021$274.18M+60.9%
Q1 FY2021Mar 31, 2021$302.32M+244.1%
Q4 FY2020Dec 31, 2020$283.69M+186.4%
Q3 FY2020Sep 30, 2020$278.68M+154.7%
Q2 FY2020Jun 30, 2020$170.41M+41.8%
Q1 FY2020Mar 31, 2020$87.86M+148.9%
Q4 FY2019Dec 31, 2019$99.06M+10.0%
Q3 FY2019Sep 30, 2019$109.40M+409.2%
Q2 FY2019Jun 30, 2019$120.20M+383.3%
Q1 FY2019Mar 31, 2019$35.30M+485.2%
Q4 FY2018Dec 31, 2018$90.07M+829.2%
Q3 FY2018Sep 30, 2018$21.48M–
Q2 FY2018Jun 30, 2018$24.87M–
Q4 FY2017Dec 31, 2017$6.03M–
Q4 FY2016Dec 31, 2016$9.69M–

More IDEAYA Biosciences figures

See a number that looks wrong?